Optimising glucocorticoid replacement in adrenal insufficiency
File(s) 499-Article Text-3767-1-10-20191216 (1).pdf (113.75 KB)
Published version
Author(s)
Meeran, Karim
Type
Journal Article
Abstract
Several different regimens for steroid replacement have been tried, but head to head studies of different treatments need to be more widely undertaken. Once daily treatment with prednisolone gives the most physiological profile, and studies comparing prednisolone with hydrocortisone are now being undertaken. It is likely that prednisolone 4mg daily will be the optimum treatment used.
Date Issued
2019-12-01
Date Acceptance
2026-12-01
Citation
The British Journal of Diabetes, 2019, 19 (2), pp.131-132
ISSN
2397-6233
Publisher
Association of British Clinical Diabetologists
Start Page
131
End Page
132
Journal / Book Title
The British Journal of Diabetes
Volume
19
Issue
2
Copyright Statement
Copyright © 2019 Copyright Owner. Published open access under a Creative Commons Attribution 4.0 International License and available at https://www.bjd-abcd.com.
License URL
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000503260100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
Addison's disease
ADDISONS-DISEASE
cortisol
Endocrinology & Metabolism
fludrocortisone
hydrocortisone
Life Sciences & Biomedicine
MODIFIED-RELEASE
pituitary
prednisolone
PREDNISOLONE
PROFILE
Science & Technology
SUBCUTANEOUS HYDROCORTISONE INFUSION
THERAPY
Publication Status
Published
Date Publish Online
2026-12-17
